JOHNSON & JOHNSON Accrued Liabilities 2008-2026 | JNJ
Beta
What is accrued liabilities?
Accrued liabilities are expenses that have been incurred but not yet paid, such as wages, interest, and taxes payable.
What is JOHNSON & JOHNSON's current accrued liabilities?
JOHNSON & JOHNSON (JNJ) annual accrued liabilities for 2025 was $8.59B, a 0.53% increase from 2024. JOHNSON & JOHNSON accrued liabilities for the quarter ending March 29, 2026 was $7.40B.
What was JOHNSON & JOHNSON's accrued liabilities in 2024?
JOHNSON & JOHNSON annual accrued liabilities for 2024 was $8.55B, a 16.28% decline from 2023.
What was JOHNSON & JOHNSON's accrued liabilities in 2023?
JOHNSON & JOHNSON annual accrued liabilities for 2023 was $10.21B, a 24.98% decline from 2022.
What is JOHNSON & JOHNSON's 4-year accrued liabilities CAGR?
JOHNSON & JOHNSON accrued liabilities grew at a compound annual growth rate (CAGR) of 11.43% from FY2021 to FY2025, going from $13.97B to $8.59B over 4 years.
Accrued Liabilities History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGR-2.4%
FY2019
$9.71B
→
FY2025
$8.59B
081011121314161718192122232425
5 years selected
Accrued Liabilities History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $8.59B | +0.5% | 10-K |
| FY2024 | $8.55B | -16.3% | 10-K |
| FY2023 | $10.21B | -25.0% | 10-K |
| FY2022 | $13.61B | -2.5% | 10-K |
| FY2021 | $13.97B | +43.8% | 10-K |
| FY2019 | $9.71B | +27.8% | 10-K |
| FY2018 | $7.60B | +4.1% | 10-K |
| FY2017 | $7.30B | +35.0% | 10-K |
| FY2016 | $5.41B | -17.4% | 10-K |
| FY2014 | $6.55B | -14.7% | 10-K |
| FY2013 | $7.68B | +5.3% | 10-K |
| FY2012 | $7.30B | +78.0% | 10-K |
| FY2011 | $4.10B | -11.4% | 10-K |
| FY2010 | $4.63B | -16.4% | 10-K |
| FY2008 | $5.53B | - | 10-K |
Company: JOHNSON & JOHNSONTicker: JNJSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →